Ritesh Jha

Ritesh Jha

Director Director DIN 07684594
DIN 07684594 First appointment Dec 2016 Primary industry Service
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2016
Shareholding value •••• Premium profile

About Ritesh Jha

Data last updated:

Ritesh Jha was a Director at Ay Medivision Private Limited (2016–2022) and Designated Partner at Life Medcare Nursing Agency Llp (2018–2019). The companies operate in Service and Business Services.

DIN 07684594
Primary Designation Director
Industry Service
First Appointment 23 Dec 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ay Medivision Private Limited U93090DL2016PTC309628
Director23 Dec 20162016Active
Designated Partner08 May 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ay Medivision Private Limited
Life Medcare Nursing Agency Llp
Premium access

Shareholding and investment profile for Ritesh Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Jha

Ritesh Jha was first appointed on 23 Dec 2016 as Director at Ay Medivision Private Limited. The most recent appointment on record is 08 May 2018 at Life Medcare Nursing Agency Llp.

Ritesh Jha held 2 earlier board appointments: Ay Medivision Private Limited (Director, 23 Dec 2016 to 18 Jun 2022); Life Medcare Nursing Agency Llp (Designated Partner, 08 May 2018 to 22 May 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available